Related Experiment Videos
[Silent ischemia. Therapeutic strategy]
1Cardiologie Clinique et Expérimentale, CHU Rangueil, Toulouse.
Insights
Silent myocardial ischemia, often painless, is common in coronary insufficiency. Effective treatment aims to reduce ischemia duration and severity, regardless of chest pain, to improve ventricular function.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Ischemic Heart Disease
Context:
- Silent myocardial ischemia is a prevalent condition associated with various forms of coronary insufficiency.
- It frequently occurs without chest pain, complicating diagnosis and management.
- Repeated ischemic episodes negatively impact ventricular function and structure.
Purpose:
- To highlight the significance of "painless" or silent myocardial ischemia in coronary artery disease.
- To emphasize the therapeutic goal of reducing ischemic burden, not just pain.
- To differentiate management strategies for silent ischemia in different clinical contexts.
Summary:
- Silent ischemia post-myocardial infarction in high-risk patients necessitates thorough investigation, medical therapy, and potentially revascularization (angioplasty or surgery).
- In stable or unstable angina, approximately 50% of ischemic events are painless; treatment focuses on minimizing ischemia duration and intensity based on diagnostic findings.
- Isolated silent ischemia requires careful diagnostic evaluation and risk stratification according to individual patient conditions.
Impact:
- Recognizing and treating silent ischemia is crucial for preventing adverse cardiovascular events.
- Tailored treatment approaches based on clinical presentation and diagnostic assessment can improve patient outcomes.
- Reducing ischemic burden is paramount for preserving myocardial function and ventricular remodeling.
Abstract:
"Painless" or silent myocardial ischemia is common and may be associated with all types of coronary insufficiency. Repeated ischemia impairs the functional and anatomical status of the ventricle and the aim of the treatment of coronary insufficiency must be to reduce not only pain, when present, but also ischemia. A distinction must be drawn between: 1) Painless ischemia after myocardial infarction occurring in a high risk group. This requires investigation of the patient, medical treatment and, according to results, angioplasty or surgery. 2) Painless ischemia associated with stable or unstable angina. It is known that in stable angina 50 per cent of ischemia attacks are painless and that complete treatment must seek to reduce the duration of ischemia. Treatment is adjusted on the basis of the results of investigations and the severity of ischemia. 3) Silent ischemia alone which requires precise diagnostic evaluation and assessment of risk based upon the patient's condition.